Baxter International Inc (NYSE:BAX)
$ 33.3 -0.78 (-2.29%) Market Cap: 16.97 Bil Enterprise Value: 28.51 Bil PE Ratio: 6.40 PB Ratio: 2.08 GF Score: 77/100

Baxter International Inc at Credit Suisse Healthcare Conference - Scottsdale Transcript

Nov 12, 2019 / 06:30PM GMT
Release Date Price: $80.1 (+1.57%)
Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

Okay. So my name is Matt Miksic, medical device analyst at Crédit Suisse. Very pleased to have with us here, Baxter, Jay Saccaro, EVP and CFO; as well as Clare Trachtman, VP, Director, IR extraordinaire.

Questions & Answers

Matthew Stephan Miksic;dit Suisse AG
CrÃ;Research Division - Senior Research Analyst

© -

So there has been a -- it's been a bit of a news build, you could say, Q3 reporting season for a number of companies in our space, Baxter being one of them. Before we kind of dive into sort of maybe the obvious topic, which we do have to kind of touch on, I wanted to give, Jay, you an opportunity as you have done a number of times as we've talked -- caught up after Q3 on what you thought was -- and I think there were some very strong aspects of results, very encouraging aspects of results, and maybe highlight some of those, and then we'll delve into what needs to be flushed out or fixed or clarified over

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot